GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (SHSE:688235) » Definitions » FCF Yield %

BeiGene (SHSE:688235) FCF Yield % : -5.01 (As of Dec. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is BeiGene FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BeiGene's Trailing 12-Month Free Cash Flow is ¥-7,491 Mil, and Market Cap is ¥149,651 Mil. Therefore, BeiGene's FCF Yield % for today is -5.01%.

The historical rank and industry rank for BeiGene's FCF Yield % or its related term are showing as below:

SHSE:688235' s FCF Yield % Range Over the Past 10 Years
Min: -15.37   Med: -8.37   Max: -0.6
Current: -5.01


During the past 11 years, the highest FCF Yield % of BeiGene was -0.60%. The lowest was -15.37%. And the median was -8.37%.

SHSE:688235's FCF Yield % is ranked better than
68.08% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs SHSE:688235: -5.01

BeiGene's FCF Margin % for the quarter that ended in Sep. 2024 was 5.46%.


BeiGene FCF Yield % Historical Data

The historical data trend for BeiGene's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeiGene FCF Yield % Chart

BeiGene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -5.33 -7.63 -6.65

BeiGene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.98 -5.89 -8.05 -3.74 0.62

Competitive Comparison of BeiGene's FCF Yield %

For the Biotechnology subindustry, BeiGene's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeiGene's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeiGene's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BeiGene's FCF Yield % falls into.



BeiGene FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BeiGene's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-12521.869 / 188360.2688
=-6.65%

BeiGene's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=387.156 * 4 / 249123.2254
=0.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BeiGene FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BeiGene FCF Yield % Related Terms

Thank you for viewing the detailed overview of BeiGene's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BeiGene Business Description

Address
c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

BeiGene Headlines

No Headlines